A pharmaceutical company issued a Class I recall of one of its drug products. Two months later, two bottles of the drug product were discovered in the inventory of a community pharmacy. The pharmacy argued to the FDA that (1) it had no knowledge of the recall; (2) even if it had knowledge, it had no responsibility to remove the products from its inventory; and (3) possession of the products for resale is not a violation of the FDCA. Are the pharmacy’s arguments valid?